Fact CheckerSign in

NCT07458217Recruiting

Combined CM and STN Stimulation for Motor Epilepsy

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

This self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centromedian (CM) thalamus deep brain stimulation (DBS) for drug resistant epilepsy with motor symptom in adults.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
4 Mar 2026
Start date
13 Oct 2026
Primary completion date
31 May 2028
Lead sponsor
Boston Scientific Corporation
Diseases
Epilepsy
NCT number
NCT07458217

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 13 Oct 2026 to the primary completion date, 31 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 2\) Previous diagnosis of psychogenic/non-epileptic seizures.
  • 3\) Brain lesion resection or ablation surgery performed less than 6 months.

Other illness

  • 1\) Non Motor Epilepsy.

Other

  • 4\) Implanted Vagus nerve stimulation (VNS) or responsive neurostimulation (RNS) devices recommended neither stimulation off the device at least 6 months nor remove the device.
  • 5\) Pregnant, breastfeeding, or having the intention to become pregnant during the study period (for females of childbearing potential).

Who the study is looking for

  • 1\) 18-65 Years.
  • 2\) Drug Resistant Epilepsy.
  • 3\) Motor Epilepsy - defined as:
    • Epilepsy diagnosis meeting ILAE criteria
    • Motor Epilepsy defined as including one or more of:
    • Tonic, Clonic, or Tonic-Clonic activity; ii. Myoclonic Jerks; iii.Epileptic Spasms; iv.Focal Motor Seizures (identified primary lesion will be in motor functional area, such as primary motor cortex (BA4), pre-motor cortex (BA6), Central Posterior Gyrus (BA1-3), or other motor region); v.Motor activity not secondary to non-motor seizure. c.Clinical or Electrographic corroboration of at least one of: i.Video-EEG confirmation of motor seizure semiology; ii.Interictal or ictal EEG findings consistent with epileptic motor network involvement; iii.Consistent clinical description by trained cliniciants.
  • 4\) \>3 Focal or Generalized seizures / month with an inter-seizure interval no great than 30 days.
  • 5\) Subject or caregiver is able to provide epileptic seizure record within 90 days prior to the surgery.
  • 6\) Voluntarily participate in the trial, sign the informed consent form, and be willing to comply with study requirements, including follow-ups.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Xuanwu Hospital Capital Medical Univers
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.